Paper · 16200064
Probing tumor phenotypes using stable and regulated synthetic microRNA precursors.
Dickins RA and 6 others. Nat Genet, 2005. Cited by 448 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Papers, record 16200064. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16200064
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genetic Vectors | Major topic |
| MicroRNAs | Major topic |
| Neoplasms | Major topic |
| RNA Interference | Major topic |
| RNA Polymerase II | Major topic |
| RNA, Small Interfering | Major topic |
| Animals | |
| Cell Proliferation | |
| Cellular Senescence | |
| Fibroblasts | |
| Mice | |
| Oncogenes | |
| Phenotype | |
| Promoter Regions, Genetic | |
| Protein Synthesis Inhibitors | |
| Tetracycline | |
| Transcription, Genetic | |
| Tumor Suppressor Protein p53 |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed and NIH |
Source NIH RePORTER
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 16,254,559 | RNAi the natural way. | https://conductscience.org/library/papers/16254559 |
Source PubMed
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by296
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 448 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,629,473 | Metastasis of triple negative breast cancer is regulated by a targetable miR-342-E2F network. | EMBO Mol Med | 2026 | https://conductscience.org/library/papers/42629473 | PubMed |
| 42,333,811 | Dual function of ERH in primary miRNA biogenesis. | Nucleic Acids Res | 2026 | https://conductscience.org/library/papers/42333811 | PubMed |
| 42,137,586 | High-titer modular retroviral vectors enabled by an antisense cassette design preventing dsRNA formation during virus production. | Mol Ther Adv | 2026 | https://conductscience.org/library/papers/42137586 | PubMed |
| 41,606,720 | KLHDC3 deficiency in mice reveals essential roles in development, survival, and adiposity via the DesCEND ubiquitin pathway. | BMC Genomics | 2026 | https://conductscience.org/library/papers/41606720 | PubMed |
| 41,426,227 | Gamma-retrovirus design for efficacious microRNA-mediated gene knock-down and protein co-expression without compromising titers. | NAR Mol Med | 2025 | https://conductscience.org/library/papers/41426227 | PubMed |
| 41,215,730 | Impaired nuclear PTEN function drives macrocephaly, lymphadenopathy and late-onset cancer in PTEN hamartoma tumour syndrome. | Dis Model Mech | 2026 | https://conductscience.org/library/papers/41215730 | PubMed |
| 40,558,465 | A Smart Nanoprobe for Visually Investigating the Activation Effect of Cyclical DOX Release on the p53 Pathway and Pathway-Related Molecules. | Biosensors (Basel) | 2025 | https://conductscience.org/library/papers/40558465 | PubMed |
| 39,967,915 | The Role of MicroRNAs in Liver Functioning: from Biogenesis to Therapeutic Approaches (Review). | Sovrem Tekhnologii Med | 2023 | https://conductscience.org/library/papers/39967915 | PubMed |
| 39,524,539 | Recent advances in methylation modifications of microRNA. | Genes Dis | 2025 | https://conductscience.org/library/papers/39524539 | PubMed |
| 39,043,718 | Mutational profiling of SARS-CoV-2 papain-like protease reveals requirements for function, structure, and drug escape. | Nat Commun | 2024 | https://conductscience.org/library/papers/39043718 | PubMed |
1 to 10 of 296
See all 296 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16200064
GET https://conductscience.org/api/papers/v1/16200064/cited_by?page=2